Related Experiment Video
Updated: Jun 28, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
[Application of metagenomic next-generation sequencing technology in preterm infants with sepsis following antibiotic
Chun-Yan Lou1, Yu-Ning Liu1, Xuan Zhang1
1Department of Neonatology, Henan Provincial People's Hospital/Zhengzhou University People's Hospital, Zhengzhou 450003, China.
Objectives:
To explore the value of metagenomic next-generation sequencing (mNGS) technology in the etiological diagnosis of sepsis in preterm infants following antibiotic use.
Methods:
A retrospective analysis of medical records for 45 preterm infants with sepsis who were treated at Henan Provincial People's Hospital. All patients received antibiotic treatment for ≥3 days and underwent both blood culture and mNGS testing. The detection rates of pathogens by blood culture and mNGS testing were compared.
Results:
The positive detection rate of pathogens by blood mNGS was higher than that by blood culture (44% vs 4%; P<0.001). Blood mNGS detected 28 strains of pathogens, including 23 bacteria, 4 fungi, and 1 Ureaplasma parvum. Blood culture identified one case each of Rhodotorula mucilaginosa and Klebsiella pneumoniae. In the group treated with antibiotics for >10 days, the positive rate of blood mNGS testing was higher than that of blood culture (40% vs 3%; P<0.001); similarly, in the group treated with antibiotics for ≤10 days, the positive rate of blood mNGS testing was also higher than that of blood culture (53% vs 7%; P=0.020). Treatment plans were adjusted based on blood mNGS results for 13 patients, with an effectiveness rate of 85% (11/13).
Conclusions:
In preterm infants with sepsis following antibiotic use, the positive rate of pathogen detection by blood mNGS is higher than that by blood culture and is unaffected by the duration of antibiotic use. Therefore, mNGS testing can be considered for confirming pathogens when clinical suspicion of infection is high but blood culture fails to detect the pathogen.
Insights
Metagenomic next-generation sequencing (mNGS) offers a higher pathogen detection rate for sepsis in preterm infants than blood culture, even after antibiotic use. This advanced diagnostic tool aids in timely and effective treatment adjustments.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Molecular Diagnostics
Background:
- Sepsis is a critical concern in preterm infants, often complicated by prior antibiotic exposure.
- Accurate etiological diagnosis is essential for guiding appropriate antimicrobial therapy in this vulnerable population.
- Traditional diagnostic methods like blood culture have limitations, especially in infants receiving antibiotics.
Purpose of the Study:
- To evaluate the diagnostic value of metagenomic next-generation sequencing (mNGS) for sepsis in preterm infants.
- To compare the pathogen detection rates of mNGS versus blood culture in preterm infants with sepsis, particularly after antibiotic treatment.
Main Methods:
- Retrospective analysis of 45 preterm infants diagnosed with sepsis.
- All infants received at least 3 days of antibiotic treatment prior to testing.
- Comparison of pathogen detection by blood culture and blood mNGS.
Main Results:
- Blood mNGS demonstrated a significantly higher pathogen detection rate (44%) compared to blood culture (4%).
- mNGS identified a diverse range of pathogens, including bacteria and fungi, irrespective of antibiotic treatment duration (>10 days or ≤10 days).
- Treatment plan adjustments based on mNGS results led to an 85% effectiveness rate.
Conclusions:
- Blood mNGS is a more sensitive diagnostic tool for identifying pathogens in preterm infants with sepsis, even post-antibiotic exposure.
- The effectiveness of mNGS is not diminished by the duration of prior antibiotic use.
- mNGS should be considered for etiological diagnosis when clinical suspicion of sepsis is high, but blood cultures are negative.
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota
Microbiota Modulation by Antibiotics
Rapid Identification of Pathogens
Automated Microbial Diagnostics

